You just read:

KIOVIG, Baxter's New IVIG Product Receives Unanimous Positive Opinion in Europe as Replacement Therapy for Immunodeficiencies and for Immunomodulation in Immune-Mediated Diseases

News provided by

Baxter Deutschland GmbH

23 Nov, 2005, 14:00 GMT